Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
TIK Another Insider Buy 3500 shares TIK reports in 2 weeks & will be very profitable now & going forward ....also Insiders own over 1.6 million shares of the 3.2 million out ...plus V Dowling almost an insider long term IRA holding 330K shares ....
Form 4 link
http://secfilings.nasdaq.com/filingFrameset.asp?FileName=0001185185-15-000172.txt&FilePath=\2015\01\29\&CoName=TEL+INSTRUMENT+ELECTRONICS+CORP&FormType=4&RcvdDate=1%2F29%2F2015&pdf=
TIK sorry I didn't update the news out last week here as Revenues came in even stronger then anticipated to 5 million $$$$. Also CEO will report Non Gaap #'s so earnings s/b .10 to .12 cents a share being reported in 2 weeks Feb release & will guide 4th Qtr to over 6 million dollars & EPS of .25 to .30 cents a share. Now that commercial launch fully underway TIK will be a steady repeatable profitable co. going forward every Qtr taking advantage of over 14 Million dollars in Net Operating Loss carry forwards offsetting taxes for the next few Years. LINK to news & again they report in about 2 weeks....
http://finance.yahoo.com/news/tel-instrument-electronics-corp-holds-133000068.html
TIK yes 30% revenue sequential increase is huge & going profitable & then adding that the next quarter will be significantly more profitable is big news imo especially when you work the numbers and TIK is trading at 4X's forward earnings
TIK wanted to alert you to an early under the radar play as TIK released a S.E.C. 14A filing late Friday at the bottom a shareholder letter & CEO stated
" With all three of our major programs now close to full rate production, with the notable exception of the TS-4530A SETS, management believes that the Company should be able to significantly improve revenues and profitability starting in the current fiscal quarter ending December 31, 2014. Absent any unexpected issues with respect to government inspections or export order approvals, third quarter revenues are anticipated to exceed the year-ago levels and should exceed $4.5 million. Further improvement is expected in the fourth quarter with the increase in TS-4530A KIT shipments and the shipment of T-47NH units to the U.S. Army.Management believes that the next fiscal year should show strong improvement based on the commencement of TS-4530A SET production, and increased deliveries of higher priced CRAFT units. Given the largely fixed cost structure of our business, this significant revenue increase should translate into strong bottom line operating results going forward."
Also for background content & imo very well done DD on what we expect from TIK in 2015 is this S/A article just a few weeks old. TIK will be profitable going forward & barring any major bad news will be very profitable going forward.
http://seekingalpha.com/article/2728295-tel-instrument-guidance-calls-for-revenues-to-quickly-double-accompanied-by-strong-earnings
ADMP & if management is honest ADMP will NOT raise $$$ at these insane levels as I have spoken to them multiple times & again NO OFFERINGS imo.....
ADMP at a 38 Mill $$ Mkt Cap & entering a 1 Bbill $$$ EPI PRN Mkt & a 8 Bill $$$ Advair market seems incredibly cheap at 38 Million bucks imo... Looks like a Yellen selloff to me
ADMP NDA filing news out this a.m. link
http://finance.yahoo.com/news/adamis-submits-drug-application-fda-121500488.html
KALO no otc bb's here blackjack
ADMP agreed some flippers but 1 seller yesterday was 125K of vol late afternoon as I know who it was... story hasn't changed just taking to long as many been in since Dec Jan....Springer is no P&D investor & will continue to update & follow ADMP...GLTA & make $$$$$$$$$$$
ADMP streetdotcom out as technical breakout for ADMP link
http://www.thestreet.com/story/12710885/2/5-stocks-under-10-set-to-soar.html
ADMP here is Springers article off S/A Pro link & $20 target
http://seekingalpha.com/article/2216473-4-reasons-adamis-pharmaceuticals-could-be-a-multi-bagger
ADMP just read Springers report $20 target NOW & s/b much higher next year when ADMP partners up after generic Advair trial very thorough report
ADMP gapper as Springers 30 page article out to Seeking Alpha Pro Members this a.m.
ADMP twitter.. Joe Springer ?@JoeSpringer 1h
$ADMP 30 pages of goodness (gracious!) submitted! Praise the deities!
Expand
ADMP Springer was out yesterday 46 pages thus far has to condense it a bunch & said will finish over the weekend so early next week is my guess .... sounded very bullish & should bode well for longs in the weeks ahead as valuation is ridiculous
ADMP took back 50 day & back over $6.00 nice $$$$ with May catalysts very close
ADMP with a 4+ mill Float & plenty of May news coming I think you will be pleasantly surprised the next few weeks GLTY & make $$$$$$
ADMP Springer has over 4000 followers & over 200 Institutional followers was 6 for 6 in 2013 picking doubles/triples or more see TNXP picked late Nov went from $4 to $21 in few months....Imo he picked a winner at 55 million $$$ market cap & a 8 drug pipeline with generating revenues early 2015 & generic advair market alone over 8 Billion $$$ a year market cap makes no sense. Imo he gets another double/triple in the weeks & months ahead GLTA & make $$$$$$$$$$$$$$$
ADMP hearing FDA meeting yesterday went well = we s/b hearing a positive PR in the days ahead & now only off 10% from base .... far far better then most Biotech's that are off 20 to 50%
ADMP in reality held up well compared to many Biotechs down about 15% when many are down 25 to 50% or more. ADMP is just cheap any way you slice it & there are multiple catalysts the next few days weeks & months
ADMP not sure if 6 months or 10 months but either way ADMP will be generating revenues in 2015 plus generic Advair trials this summer & will be short 12 weeks so data out by 4th Qtr.... At 55 million dollar market cap is plain nuts imo with the pipeline they have...
ADMP well FDA meeting Mon April 21 & NDA of generic Epi pen in the days after meeting s/b a catalyst also Joe Springer in depth DD & coverage starting has over 3300 followers & specializes in only stocks with double/triple potential or more was 6 for 6 in 2013 & last one TNXP went from $4 where he started alerting & went to $21 over the next 2 months.
http://seekingalpha.com/instablog/1117866-joe-springer/2824873-the-adamis-family
http://seekingalpha.com/article/2131233-adamis-pharmaceuticals-still-no-love-after-uplisting-to-nasdaq
ADMP Back in $4.80 to where it bounced to $6's dirt cheap & FDA meeting next Mon & NDA filing later in week plus CC after filing updating entire pipeline. So catalysts next week should = nice entry here even just for trade imo....Market cap under 50 Mill $$$$ seems nuts to me
ADMP another article I saw over the weekend Vol & awareness growing for ADMP... Also don't forget FDA meeting April 21st & NDA filing for generic Epi Pen days after if all goes as planned.
http://microcapmarketplace.com/2014/04/10/recent-sell-off-for-adamis-admp-overdone/
ADMP another article I saw over the weekend Vol & awareness growing for ADMP
http://microcapmarketplace.com/2014/04/10/recent-sell-off-for-adamis-admp-overdone/
ADMP Joe Springer just posted about an upcoming in depth article on ADMP. For those of you who don't know who Joe Springer is he is a seeking alpha pro author who only specializes in stocks with double to triple potential or more. In 2013 was 6 for 6 in double/triples or more & his last one was TNXP which once his report was out went from $4 to $21 in weeks link
http://seekingalpha.com/instablog/1117866-joe-springer/2824873-the-adamis-family
ADMP Joe Springer didn't publish his article yet just a preview in the link I provided. The seeking alpha out yesterday was from a guy Joe Natural a different author. Joe Springer has almost 3300 followers and his stuff is usually in depth.
ADMP Joe Springer just posted about an upcoming in depth article on ADMP. For those of you who don't know who Joe Springer is he is a seeking alpha pro author who only specializes in stocks with double to triple potential or more. In 2013 was 6 for 6 in double/triples or more & his last one was TNXP which once his report was out went from $4 to $21 in weeks link
http://seekingalpha.com/instablog/1117866-joe-springer/2824873-the-adamis-family
ADMP $5.79 HOD on big Volume again chart turn as money stream & balance of power turned positive today. Hope many took advantage in $4.90's GLTA & make $$$$$$$$$$$$$$$$$$$$$$$
ADMP best Vol of the year very bullish imo s/b back in $6's very soon GLTA & make $$$$$
ADMP nice seeking alpha article just out well written link
http://seekingalpha.com/article/2131233-adamis-pharmaceuticals-still-no-love-after-uplisting-to-nasdaq
ADMP seeking alpha article out well written link
http://seekingalpha.com/article/2131233-adamis-pharmaceuticals-still-no-love-after-uplisting-to-nasdaq
ADMP good vol as well maybe back to $6's today ...
ADMP seems the storm is passing & reversal soon for tiny float ADMP remember float under 4.8 million shares so big swings both up & of course down wowsa the last 4 days....great spot even for trading shares GLTA & make $$$$$$$$$$$$$$$$$$$$$$$$$$
Credit Suisse says grit your teeth & buy Biotech link
http://247wallst.com/healthcare-business/2014/04/07/credit-suisse-says-grit-your-teeth-and-buy-biotech/#ixzz2yCwwJq1k
Great advice sheff especially about knowing what works for you as all traders different .... If I had to daytrade for a living I'd live in a cardboard box 4 sure lol..... swings holding good DD co.s for weeks & months has been my ticket... to each his own though GLTA & make $$$$$$$$$$$$$$
ADMP Appreciate the prayers gotta know what you own & have patience for it to play out was in similar boats in APPY at $1.15 TKMR bought in $5's went to $4's then boom ARWR same thing WYY at .90 went to .70 before going to $2 FONR 1 of my biggest $$ wins took 6 months to play out $5's to $25's etc etc .... Good DD & patience has been my recipe for very large $$$ wins for years now.... GLTA & make $$$$$$$$$ as imo 50 million for any small Biotech with 1 drug in pre clinical or phase 1 s/b valued here not 1 with 8 drugs 1 going for FDA approval 3 in phase 3 trials & 1 DNDN type Cancer vaccine going into phase 2 for 50 million $$$ ??? Nuts considering Branded Generic Advair alone is a 8 Billion dollar worldwide market with NO generics even though off patent since 2010 as many big Pharmas have failed in coming up with a delivery system for dual drug in Advair. 100 Billion Dollar 3M did build a better mousetrap & now ADMP has it & partnering with 3M as they retain all manufacturing rights....3M has had a hand in a high % of all inhalers the last 50 years a very rich history indeed.
ADMP cash burn low right now as NDA already complete waiting on FDA meeting on April 21st & Advair trials start in summer as well as steroid inhaler trial so I'm sure costs will rise this summer when phase 3's start....ADMP s/b ok $$$ wise till 1st Qtr 2015 imo....
ADMP a very low float under 5 mill shares as Institutions accumulated 4.7 million shares the last 4 months & Insiders own over 900K so as fast as it went down a buck on few hundred K it sure can go up just as fast imo.... 50 Million dollar market cap for 8 drug pipeline with 1 going for FDA approval 3 Phase 3 trials & 1 phase 2 trial is crazy & over 7 million in cash
ADMP Adamis Pharma defended premarket at CRT Capital (5.60 +0.00)
CRT Capital believes yesterday's weakness in ADMP was tied to the restructuring of their remaining $600K convert -- given the extended maturity and lower strike the perception is that they don't have enough cash to pay it off, but this is untrue. With $7 mln in cash and a $240K/month burn rate, co has ample cash for this year. The fundamentals are unchanged and firm continues to highlight their solid respiratory franchise plus free option on their epinephrine pre-filled syringe. The EpiPen comp is a huge opportunity -- with filing by the end of this month and potential approval by year end, even a sliver of the anaphylaxis market makes the stock a double.